grant PAR-23-268

Extracellular Vesicle Therapeutics: STTR Industrialization & Translation for Regenerative Medicine (no clinical trials)

STTR cooperative agreements to develop and industrialize extracellular vesicle (EV) therapeutic platforms for regenerative medicine, emphasizing production, manufacturing, and platform-oriented technology development for both native and engineered EVs. The funding targets translation and scale-up activities to enable EVs as therapeutics; clinical trials are not allowed under this announcement.…

This FOA provides support using the STTR cooperative agreement mechanisms for the development of novel extracellular vesicle-based therapeutic platforms for use in regenerative medicine. Both native and engineered EVs have demonstrated the ability for specific and targeted tissue and organ repai…

Funding Source

Agency: National Institutes of Health

Awards & funding

Award Ceiling: $295,924

Eligibility

Small businesses

Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.S…

Supporting links

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.